Assessment and Management of Alveolar Hemorrhage

Immediate Diagnostic Assessment

The American College of Physicians recommends suspecting DAH in any patient presenting with acute respiratory failure, hemoptysis, and bilateral pulmonary infiltrates on imaging, even without prior history of systemic disease 1
Rapidly progressive respiratory failure with or without renal involvement is the classic presentation of DAH 1
Bronchoscopy with bronchoalveolar lavage is the gold standard for diagnosing DAH, showing progressively bloodier returns in sequential aliquots 1
The European Respiratory Society suggests obtaining chest CT showing bilateral ground-glass opacities and consolidation to aid in diagnosis 1
Drawing baseline labs urgently, including ANCA antibodies, anti-GBM antibodies, ANA, complement levels, coagulation studies, and cross-match for blood products, is crucial for etiologic workup 2, 1

The American Thoracic Society recommends initiating IV methylprednisolone 500-1000 mg/day for 3 consecutive days, then transitioning to high-dose oral prednisone, for patients with suspected immune-mediated DAH and hypoxemia 1
Combining glucocorticoids with either rituximab or cyclophosphamide for remission induction is recommended by the American College of Rheumatology 1
Considering plasma exchange for DAH with hypoxemia, particularly if serum creatinine is elevated, requiring dialysis, or rapidly increasing, is suggested by the American Society for Apheresis 1
Securing large-bore IV access and administering high-flow oxygen, with intubation for mechanical ventilation if hypoxemic respiratory failure develops, is recommended by the American Association for Respiratory Care 1
Using lung-protective ventilation with tidal volumes 6-8 mL/kg predicted body weight, plateau pressure ≤30 cmH₂O, and moderate PEEP 6-8 cmH₂O is suggested by the American Thoracic Society 1

The American College of Physicians recommends requiring the most aggressive approach for anti-GBM disease, including immediate cyclophosphamide, high-dose glucocorticoids, and plasmapheresis 1
The European Renal Association suggests considering avacopan as adjunctive therapy to reduce glucocorticoid exposure in high-risk patients with ANCA-associated vasculitis 1

The American Thoracic Society recommends avoiding manual hyperinflation, postural drainage with head-down positioning, percussion, vibratory shaking, or forced expiration techniques, as they worsen hemorrhage 1
The American Association for Respiratory Care suggests avoiding vasopressors until bleeding is controlled, and using warmed blood products when transfusion is needed 2, 5

The American College of Physicians recommends tracking PaO₂/FiO₂ ratio, chest imaging for resolution of ground-glass opacities, and serial hemoglobin levels to monitor disease progression 1
The European Respiratory Society suggests monitoring coagulation parameters, blood gases, and assessing for ongoing bleeding 2, 3
Initiating venous thromboprophylaxis as soon as bleeding is controlled is recommended by the American College of Chest Physicians 2, 3, 1